01 Increasing Adoption of Integrated Diabetes Technology Automated insulin delivery systems can use continuous glucose monitoring data to adjust insulin administration, reducing the need for patients to make every dosing decision manually. This integration is moving diabetes management from individual devices toward coordinated technology ecosystems. In January 2026, the American Diabetes Association's updated Standards of Care recommended automated insulin delivery systems as the preferred insulin-delivery approach for people with type 1 diabetes who can use the technology safely.
02 Growing Use of Continuous Glucose Monitoring Beyond Insulin Users Healthcare providers are increasingly considering CGM for people with type 2 diabetes who use non-insulin glucose-lowering medications, while over-the-counter systems are also broadening access to glucose information. This is expanding the role of continuous monitoring across a wider range of diabetes-management pathways. In January 2025, the American Diabetes Association added a recommendation to consider real-time or intermittently scanned CGM for adults with type 2 diabetes using glucose-lowering medications other than insulin.
01 Rising Global Diabetes Prevalence Expands the Treatment Population Diabetes requires continuing management to control blood glucose and reduce the risk of complications, making the expanding patient population a fundamental source of demand across the diabetes-management ecosystem.
01 Limited Treatment Access in Lower-Resource Settings Diabetes management depends on consistent access to medicines, monitoring supplies, healthcare professionals, and follow-up care. In lower-resource settings, limited availability and affordability of these services can prevent patients from maintaining recommended treatment plans. Unequal healthcare access therefore restricts the adoption of advanced management solutions and reduces treatment continuity.
01 Expansion of Digital and Virtual Diabetes Management Digital health platforms, connected devices, mobile applications, and virtual coaching can extend diabetes-management support beyond conventional clinical visits. Greater integration of digital services with diabetes-management programs creates opportunities to improve continuity of care and reach underserved patient populations.
01 Complexity of Diabetes Technology Can Hinder Effective Use Rapid technology development can also make it difficult for clinical teams to remain familiar with newly introduced systems. In January 2026, the American Diabetes Association emphasized that users of automated insulin delivery systems should receive education on device operation and troubleshooting at regular intervals, reflecting the continuing challenge of managing increasingly complex diabetes technologies.
June 2026 Abbott expanded its diabetes care portfolio by launching next-generation continuous glucose monitoring (CGM) solutions featuring enhanced accuracy, longer wear time, and improved digital connectivity for people with diabetes.
April 2026 Dexcom introduced upgraded CGM technology with advanced predictive glucose alerts, improved sensor performance, and expanded integration with digital health platforms and automated insulin delivery systems.
January 2026 Medtronic expanded its diabetes management portfolio by launching enhanced insulin pump and continuous glucose monitoring solutions designed to improve automated insulin delivery and personalized diabetes care.
October 2025 Roche Diabetes Care expanded its digital diabetes management ecosystem by introducing upgraded blood glucose monitoring solutions with improved connectivity, data analytics, and remote patient management capabilities.